Analyst picks & changes

Genzyme Corp.

(GENZ)

The company told analysts that results of the pivotal study of its

HAL-F

hyaluronic acid product to prevent surgical adhesions in patients undergoing intestinal surgery exceeded its expectations (see Clinical Results, page B5).

Read the full 382 word article

How to gain access

Continue reading with a
two-week free trial.